Wesbanco Bank Inc. boosted its position in shares of The Clorox Company (NYSE:CLX – Get Rating) by 28.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,207 shares of the company's stock after purchasing an additional 715 shares during the quarter. Wesbanco Bank Inc.'s holdings in Clorox were worth $450,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CLX. American Century Companies Inc. boosted its holdings in shares of Clorox by 18.0% during the 1st quarter. American Century Companies Inc. now owns 8,320 shares of the company's stock valued at $1,157,000 after acquiring an additional 1,269 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in shares of Clorox by 6.8% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 16,465 shares of the company's stock valued at $2,289,000 after acquiring an additional 1,044 shares during the last quarter. Cibc World Market Inc. boosted its holdings in shares of Clorox by 276.6% during the 1st quarter. Cibc World Market Inc. now owns 9,318 shares of the company's stock valued at $1,295,000 after acquiring an additional 6,844 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Clorox by 0.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 683,818 shares of the company's stock worth $95,073,000 after purchasing an additional 5,145 shares during the period. Finally, Blair William & Co. IL lifted its stake in shares of Clorox by 81.1% in the 1st quarter. Blair William & Co. IL now owns 24,525 shares of the company's stock worth $3,410,000 after purchasing an additional 10,981 shares during the period. 79.12% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Up 0.2 %

Clorox stock opened at $157.76 on Tuesday. The stock has a market cap of $19.49 billion, a P/E ratio of 45.07, a PEG ratio of 3.18 and a beta of 0.29. The company has a debt-to-equity ratio of 5.04, a current ratio of 0.86 and a quick ratio of 0.47. The Clorox Company has a 1 year low of $120.50 and a 1 year high of $160.59. The firm's 50 day moving average price is $150.79 and its 200-day moving average price is $145.03.

Clorox (NYSE:CLX – Get Rating) last released its quarterly earnings data on Thursday, February 2nd. The company reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.32. The firm had revenue of $1.72 billion for the quarter, compared to analysts' expectations of $1.66 billion. Clorox had a net margin of 6.16% and a return on equity of 89.97%. The company's revenue for the quarter was up 1.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.66 earnings per share. On average, equities analysts predict that The Clorox Company will post 4.23 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 12th. Investors of record on Wednesday, April 26th will be issued a $1.18 dividend. This represents a $4.72 dividend on an annualized basis and a dividend yield of 2.99%. The ex-dividend date of this dividend is Tuesday, April 25th. Clorox's dividend payout ratio (DPR) is presently 134.86%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Jefferies Financial Group increased their price objective on shares of Clorox from $140.00 to $145.00 and gave the stock a "hold" rating in a research note on Wednesday, February 1st. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Clorox from $152.00 to $147.00 in a research note on Monday, March 20th. Raymond James raised their target price on shares of Clorox from $160.00 to $165.00 and gave the stock an "outperform" rating in a research note on Friday, February 3rd. StockNews.com began coverage on shares of Clorox in a research note on Thursday, March 16th. They set a "hold" rating on the stock. Finally, Morgan Stanley raised their target price on shares of Clorox from $142.00 to $145.00 and gave the stock an "equal weight" rating in a research note on Friday, February 3rd. Seven investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $141.00.

Clorox Profile

(Get Rating)

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.

Featured Stories

• Get a free copy of the StockNews.com research report on Clorox (CLX)
• 3 High Yields On Breakout Watch With Analyst Tailwinds
• Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
• 3 Financials The Insiders Are Buying
• Can Carnival Cruise Lines Set Sail For New Highs?
• If Safety is Your Concern, Then Take a Look at Sandy Spring Bank

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.